(Hypertension. 1995;26:1060-1064.)
© 1995 American Heart Association, Inc.
Articles |
From Bockus Research Institute, The Graduate Hospital, and the Department of Physiology, University of Pennsylvania, Philadelphia.
| Abstract |
|---|
|
|
|---|
20°C) with the use of
whole-cell, patch-clamp methods. Maximum values of calcium
current measured at 0 mV from a holding potential of -90 mV were
larger in SHR myocytes (105±11 versus 149±15 pA). Values of cell
capacitance were smaller in SHR (29.5±1.3 pF) compared with WKY
(35.0±1.5 pF) myocytes. Cell capacitance measures surface membrane
area and, when used to normalize calcium currents, magnified the
difference between WKY and SHR to approximately 47%. There was a
larger percent reduction of maximum calcium current at holding
potentials of -60 and -40 mV in SHR compared with WKY
myocytes: for example, at -40 mV calcium current was reduced from
values at -90 mV by -73±2% in SHR compared with
-58±1% in WKY. When divided by the maximum current for each
holding potential, the voltage dependence of normalized calcium
currents for the two groups was completely superimposed. Difference
currents were calculated by subtracting currents measured from holding
potentials of -90 and -40 mV. The voltage dependence of
difference currents was identical to that of the calcium currents
measured from the two values of holding potential. The results of this
study indicate that (1) only L-type calcium currents are present in
freshly isolated mesenteric artery myocytes from 20-week-old WKY
and SHR, and (2) these currents are larger in SHR. These differences in
calcium currents may contribute to augmented contractile responses that
have been previously reported.
Key Words: patch-clamp techniques calcium channels rats, inbred SHR
| Introduction |
|---|
|
|
|---|
There are two pathways for Ca2+ influx in vascular smooth muscle: one activated by agonists (receptor-operated channels) and the other activated by membrane potential (voltage-operated channels).8 There is also evidence that agonist activation is associated with membrane depolarization.7 9 Therefore, both receptor- and voltage-operated channels could contribute to force maintenance associated with agonist activation in smooth muscle.
It is well established that hypertension in human as well as animal models is associated with augmented contractile responses as well as increased sensitivity to agonist activation.10 11 12 Also, in smooth muscle it has been shown that force maintenance is closely linked to membrane potential.2 7 9 This suggests the possibility that differences in voltage-dependent Ca2+ channels may contribute to the increased contractile responsiveness in hypertension.13
A number of previous studies have documented differences in the properties of voltage-dependent Ca2+ channels between Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR).14 15 16 17 18 19 These studies were performed with high concentrations of Ca2+ or Ba2+ (ie, 10 to 50 mmol/L) as the charge carrier to improve resolution of small Ca2+ currents in rat vascular myocytes. However, the use of high concentrations of charge carrier may not provide an accurate representation of differences in the properties of Ca2+ channels in hypertension.20
The objective of these experiments was to test the hypothesis that augmented Ca2+ currents through voltage-dependent channels occur in hypertension at physiological levels of [Ca2+]o. To test this hypothesis, experiments were performed to determine the properties of voltage-dependent Ca2+ channels in myocytes freshly isolated from small mesenteric arteries of 20-week-old male WKY and SHR at 2 mmol/L [Ca2+]o.
| Methods |
|---|
|
|
|---|
Electrophysiological Methods
Membrane currents were recorded with the use of the
whole-cell, patch-clamp configuration22 at room
temperature (
20°C). Micropipettes (2 to 3 M
resistance) were
made from capillary tubing (WPI Kwik-fil) with a programmable
puller (model P-80/PC, Sutter Instruments) and fire polished. The
solution used to fill the patch pipettes had the following composition
(mmol/L): CsCl 100, tetraethylammonium
chloride 20, NaCl 5, Mg-ATP 5, HEPES 10, and BAPTA 10, with pH 7.2
(titrated with CsOH) and an osmolality of 306±3 mOsm. Series
resistance and capacitance compensation were adjusted maximally with
the use of a patch-clamp amplifier with a 100-M
head stage
(model 8900, Dagan). Experimental protocols were controlled with the
use of a computer (Dell) and PCLAMP software (Axon
Instruments). Current signals were converted from analog to digital
form at a sampling rate of 2 kHz with the use of a Labmaster A/D board
(Axon Instruments) and stored in the computer for analysis.
Multiple responses to small (20 mV) hyperpolarizing voltage-clamp
steps (n=5) were obtained for each protocol, averaged, and used to
provide capacitance and leak compensation of the raw data. Experimental
current records were analyzed with the use of
PCLAMP software.
Procedures
Cell break-in was accomplished by gentle suction at a
holding potential of -60 mV. Membrane potential was stepped at
10-second intervals from -60 to +10 mV for 3 to 5 minutes during
cell dialysis with the pipette solution until the inward
Ca2+ current (ICa)
stabilized. Current-voltage relations were then determined from a
holding potential of -60 mV. Voltage-clamp steps 75
milliseconds long were applied from -60 to +40 mV in 10-mV
increments every 10 seconds. Similar current-voltage relations were
also determined from holding potentials of -40 and -90 mV
in random order. Another current-voltage relation was determined
from a holding potential of -60 mV to test for time-dependent
changes (ie, run-down). If peak current changed more than 10%
between the first and second sets of measurements from the -60 mV
holding potential, the cell was discarded.
Statistical Analysis
We performed statistical comparisons of membrane currents with a
two-way ANOVA with repeated measures for unpaired data using the
STATWORKS application on a Macintosh computer. Values of
P<.05 were considered significant. Average values are given
as mean±1 SEM.
| Results |
|---|
|
|
|---|
|
Values of peak current measured at the various test voltages in each cell were normalized by dividing by the maximum value of ICa for each cell before averaging. As shown in Fig 1B, there was a small but significant shift in the voltage dependence of normalized ICa in SHR in the negative voltage direction by approximately 4 mV. Values of cell capacitance were determined from the transient response to a small hyperpolarizing voltage-clamp step that activated no channels.20 Values of cell capacitance were significantly smaller in the SHR compared with the WKY group (WKY, 35.0±1.5 pF; SHR, 29.5±1.3 pF; P>.001). Thus, the larger current in SHR was not the result of a larger cell size (cellular hypertrophy).
To determine whether more than one Ca2+ channel type contributed to whole-cell Ca2+ current in this study, several experiments were performed. In the first set of experiments, values of ICa were measured at the end of a 75-millisecond voltage-clamp step from a holding potential of -90 mV and compared with peak values of ICa at the same test voltages. If a low voltage activated, rapidly inactivating Ca2+ current (ie, T-type) existed in these cells, the late current would be (relatively) inactivated more at negative compared with positive voltages, and the current-voltage curve would be shifted in the positive voltage direction. Fig 2 shows normalized current-voltage curves for peak and late currents in WKY and SHR myocytes. For both groups of cells, the curves for the late current were shifted in the hyperpolarizing direction (to the left) for voltages negative to the peak ICa but were not different for voltages positive to the peak ICa. This suggests that the rate of ICa inactivation was slower at voltages between -40 and -10 mV compared with that at voltages above 0 mV and not the converse, as would be predicted if T-type channels were present in the former voltage range.
|
In the second set of experiments, ICa was measured from three different holding potentials: -40, -60, and -90 mV. If multiple Ca2+ channel types were present in these cells, then differences in current-voltage relations would exist because of the known differences in kinetics and gating properties of different Ca2+ channel types.23 Fig 3 summarizes the effects of varying holding potentials on Ca2+ current-voltage relations in WKY and SHR. As the holding potential was decreased from -90 mV, values of ICa were uniformly decreased in both WKY and SHR at all test voltages. For WKY, values of peak ICa averaged 34±4 pA at -40 mV, 95±9 pA at -60 mV, and 109±11 pA at -90 mV. For SHR, values of ICa averaged 39±5 pA at -40 mV, 117±12 pA at -60 mV, and 149±15 pA at -90 mV. There was a larger percent reduction in peak ICa in SHR when the holding potential was reduced from -90 to -60 mV (WKY, -12±4%; SHR, -17±4%) as well as from -90 to -40 mV (WKY, -58±1%; SHR, -73±2%). Only the differences at -40 mV holding potential were statistically significant, however.
|
The voltage dependence of ICa did not appear to be substantially different for the three values of holding potential. Peak values of ICa occurred at 0 mV for all three values of holding potential in the two animal groups (Fig 3). When values of ICa were normalized by the peak value of ICa at each holding potential, there was no apparent difference in their voltage dependence, as shown in Fig 4. This suggests that both groups of myocytes possess a single type of Ca2+ channel and that more positive holding potentials produce inactivation of a portion of the total ICa available.
|
A detailed examination of the Ca2+ currents measured at specific values of voltage (Fig 5) revealed relatively monotonic behavior in the effects of holding potential on the inactivation portion of ICa. When activated from a hyperpolarized holding potential (-90 mV) at which all Ca2+ channels should be available for activation, ICa at -20 mV exhibited relatively slow activation followed by slow inactivation kinetics in both WKY and SHR. At 0 mV, where the maximum ICa occurred, the rates of activation and inactivation were faster. At +20 mV, where ICa was smaller than its peak value (at 0 mV), the rate of inactivation after the peak current remained fast. At progressively more depolarized values of holding potential, the amplitude of the peak ICa decreased, as did the rate of inactivation, but the relative differences at the three test voltages were similar. These results do not indicate the presence of a rapidly inactivating ICa component activated from a hyperpolarized holding potential, where a T-type ICa component might be expected to be found.23
|
In some of these experiments, currents were recorded over the same
range of test potentials from holding potentials of -40 and
-90 mV. Differences between currents (
ICa) were
calculated by point-by-point subtraction of currents
recorded at the same value of voltage from the two different
holding potentials. Normalized current-voltage relations were
determined by dividing by the maximum value of
ICa for
each cell. As shown in Fig 6, the voltage dependence of
ICa was identical to that of the currents recorded
at the two holding potentials. This also suggests the presence of a
single channel type in which availability is inhibited by voltage.
|
| Discussion |
|---|
|
|
|---|
Previous studies of Ca2+ currents in WKY and SHR myocytes using patch-clamp methods have provided varying results. Rusch and Hermsmeyer,14 15 using 20 mmol/L [Ca2+]o, showed similar maximum Ca2+ currents in cultured myocytes obtained from the azygous vein of neonatal animals but with a larger ratio of L-type to T-type current components in the SHR. Ohya et al,17 using 50 mmol/L [Ba2+]o, compared IBa in myocytes isolated from mesenteric artery branches of young (4 to 5 weeks) and older (16 to 18 weeks) WKY and SHR. They found larger maximum IBa in myocytes from young SHR but no differences in older ones, and they found no differences in cell capacitance or in the voltage dependence of activation or inactivation at either age. Self et al,18 using 20 mmol/L [Ba2+]o, found larger IBa in cultured myocytes from the azygous vein of neonatal stroke-prone SHR. Wilde et al,19 using 10 mmol/L [Ba2+]o, found larger IBa in myocytes from cerebral arteries of 17-week-old stroke-prone SHR compared with WKY.
The present study is the first to show larger ICa in SHR myocytes compared with WKY at physiological levels of [Ca2+]o. Also, the maximum values of ICa reported in this study are equal to or larger than some of the values reported by others despite the lower concentration of charge carrier. There are obvious differences in these various studies (including this one) that could have contributed to the differences in Ca2+ channel currents reported. These include differences in the animal model (SHR or stroke-prone SHR), blood vessels (azygous vein and mesenteric and cerebral arteries), and charge carrier (10 to 50 mmol/L Ca2+ or Ba2+). Thus, the extent to which the use of larger concentrations of divalent charge carrier may have contributed to the differences in the results is somewhat obscured by the other differences.
Most of the previously cited studies reported the presence of both L- and T-type currents in the whole-cell recordings from depolarized holding potentials. The T- and L-type currents have been identified and separated on the basis of holding potential,19 test potential,17 or both.14 15 16 18 Most of these previous studies have found smaller ratios of T- to L-type currents in myocytes from hypertensive animals.14 15 16 17 19
We found evidence in this study which suggests that mesenteric myocytes
from the SHR possess only one type of Ca2+ channel,
the L-type. That evidence may be summarized as follows: (1) In
comparison with peak ICa, current-voltage curves
determined after a significant amount of time was allowed for
ICa inactivation were shifted to the left, suggesting
slower rates of inactivation at negative test voltages, rather than
shifted to the right, as would be expected if significant T-type
currents had been present (faster inactivation). (2) Measurement of
the time course of ICa at different holding potentials
revealed no low-voltage activated, rapidly inactivating
currents. (3) While currents were smaller at depolarized holding
potentials, when ICa was normalized by the maximum
ICa the resulting current-voltage curves were
superimposable. (4) The maximum value of ICa at the various
holding potentials occurred at the same voltage. (5) Difference
currents (
ICa) determined from ICa measured
from holding potentials of -90 and -40 mV had the same
voltage dependence as the original currents from which they were
derived. (6) Nisoldipine (1 µmol/L) completely inhibited the
ICa recorded from a holding potential of -90 mV
(data not shown). The reasons for the differences between the findings
of this study and previous ones is not clear, although type of
Ca2+ channel and detection of increased
Ca2+ current amplitude may arise from differences in
blood vessel source, animal ages, and selection of external solution
composition.
There are considerable data in the literature to suggest that augmented Ca2+ influx through L-type Ca2+ channels contributes to augmented peripheral resistance and contractile responses of vascular smooth muscle in hypertension. Increased peripheral resistance and augmented contractile responses to vasoconstrictors are hallmarks of established hypertension in human as well as animal models.24 25 These changes are associated with an increase in basal Ca2+ influx as well as augmented Ca2+ influx after agonist activation in vascular smooth muscle.26 27 28 The effectiveness of organic Ca2+ channel blockers in reducing blood pressure, peripheral resistance, and vasoconstrictor responses in smooth muscle is larger in hypertensive subjects.29 30 31 32 33 This suggests that altered L-type Ca2+ channels play a greater role in agonist-mediated responses in hypertension. The alterations in voltage-gated Ca2+ channels in hypertension reported in this study may provide an explanation for these varied observations.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received June 19, 1995; first decision August 18, 1995; accepted September 5, 1995.
| References |
|---|
|
|
|---|
1- and
2-adrenoceptors in several blood vessels isolated from
the rabbit. Br J Pharmacol. 1990;99:253-260. [Medline]
[Order article via Infotrieve]
1-adrenoceptor
stimulation in spontaneously hypertensive rat caudal artery.
J Cardiovasc Pharmacol. 1987;10:205-212. [Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
![]() |
S. Sonkusare, M. Fraer, J. D. Marsh, and N. J. Rusch Disrupting Calcium Channel Expression To Lower Blood Pressure: New Targeting of a Well-Known Channel Mol. Interv., December 1, 2006; 6(6): 304 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-J. Fu, M.-J. Xie, L.-F. Zhang, H.-W. Cheng, and J. Ma Differential activation of potassium channels in cerebral and hindquarter arteries of rats during simulated microgravity Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1505 - H1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pesic, J. A. Madden, M. Pesic, and N. J. Rusch High Blood Pressure Upregulates Arterial L-Type Ca2+ Channels: Is Membrane Depolarization the Signal? Circ. Res., May 28, 2004; 94(10): e97 - e104. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Pratt, S. Bonnet, L. M. Ludwig, P. Bonnet, and N. J. Rusch Upregulation of L-Type Ca2+ Channels in Mesenteric and Skeletal Arteries of SHR Hypertension, August 1, 2002; 40(2): 214 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. R. Borges, T. Feres, L. M. Vianna, and T. B. Paiva Effect of Cholecalciferol Treatment on the Relaxant Responses of Spontaneously Hypertensive Rat Arteries to Acetylcholine Hypertension, October 1, 1999; 34(4): 897 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Cox and S. Petrou Ca2+ influx inhibits voltage-dependent and augments Ca2+-dependent K+ currents in arterial myocytes Am J Physiol Cell Physiol, July 1, 1999; 277(1): C51 - C63. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Simard, X. Li, and K. Tewari Increase in Functional Ca2+ Channels in Cerebral Smooth Muscle With Renal Hypertension Circ. Res., June 29, 1998; 82(12): 1330 - 1337. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |